Search

everythinglearnresearchcommunity

for

Search:↓

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Early hair loss may indicate risk of insulin resistance.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

Lower ghrelin levels and certain gene variations may increase acne risk.

Cardiac risk markers help assess heart risk in males with type 2 diabetes and low DHT.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Many female medical students in Saudi Arabia show signs of insulin resistance linked to increased waist size.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.

People with more than 11 skin tags, especially on the thigh, neck, or armpit, may have a higher chance of metabolic syndrome.

Anorexia Nervosa and Bulimia Nervosa are complex eating disorders with increasing incidence among young females, significant morbidity, and varying mortality rates, requiring more research for better treatment.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Children with classic congenital adrenal hyperplasia have thicker heart fat and are at higher risk for heart problems and early atherosclerosis.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

Exercise and finasteride together improve ovary health in PCOS rats.

Androgenetic alopecia is linked to a higher risk of metabolic syndrome.

Metformin may help regulate periods and cause modest weight loss in PCOS patients, but more research is needed.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.

Indian women with PCOS may need different ultrasound criteria for diagnosis than current standards.

Obese and lean women with PCOS have different symptoms and need different treatments.

Obesity significantly affects skin health, causing conditions like acanthosis nigricans and skin tags, and should be considered during skin exams.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.